Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mylan Of U.S. Seeks To Buy 15 Percent Of India’s Famy Care

This article was originally published in PharmAsia News

Executive Summary

U.S. generics maker Mylan is negotiating with Famy Care of India to buy a 15 percent share in India's leading maker of contraceptives. The deal would be Mylan's second in India--it bought a 51 percent stake earlier in Matrix Labs. Mylan and Famy already have a marketing pact to sell Famy products in the United States. Famy's managing director, Sanjeev Taparia, would not confirm the Mylan deal, but acknowledged his company was looking to sell some equity. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts